Advertisement

In Vivo Magnetic Resonance Spectroscopy: Basic Principles and Clinical Applications in Oncology

  • W. Semmler
Conference paper
Part of the ESO Monographs book series (ESO MONOGRAPHS)

Abstract

In the past years magnetic resonance imaging (MRI) had a great impact in diagnostics. It has been shown that MRI has a high sensitivity, however, specificity is lacking.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sostman HD, Armitage IM, Fischer JJ (1984) N M R in cancer I. High resolution spectroscopy of tumors. Magn Reson Imag 2:265–278CrossRefGoogle Scholar
  2. 2.
    Evanochko WT, Ng TC, Lilly MB, Lawson AJ, Corbett TH, Durant JR, Glickson JD (1983) In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia. Proc Natl Acad Sci 80:334–338CrossRefGoogle Scholar
  3. 3.
    Naruse S, Horikawa Y, Tanaka C, Higuchi T, Ueda S, Hirakawa K, Nishikawa H, Watari H (1985) Observations of energy metabolism in neuroectodermal tumors using in vivo 31P-NMR. Magn Res Imag 3:117–123CrossRefGoogle Scholar
  4. 4.
    Ng TC, Evanochko WT, Hiramoto RN, Ghanta VK, Lilly MB, Lawson AJ, Corbett TH, Durant JR, Glickson JD (1982) 31P NMR spectroscopy of in vivo tumors J Magn Reson 49:271–286Google Scholar
  5. 5.
    Sijens PE, Bovée WMMJ, Seijkens D, Los G, Rutgers DH (1986) In vivo 31P-nuclear magnetic resonance study of the response of a murine mammary tumor to different dose of γ-radiation. Cancer Res 46:1427–1432Google Scholar
  6. 6.
    Bárány M, Glonek T (1984) Identification of diseased states by phosphorus-31 NMR. In: Gorenstein DG (ed) Phosphorus-31 NMR, principles and applications. Academic, OrlandoGoogle Scholar
  7. 7.
    Evanochko WT, Sakai TT, Ng TC, Rama Krishna N, Kim HD, Zeidler RB, Ghanta VK, Brockman RW, Schiffer LM, Braunschweiger PG, Glickson JD (1984) NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances. Biochim Biophys Acta 805:104–116CrossRefGoogle Scholar
  8. 8.
    Luyten PR, den Hollander JA, Segebarth C, Balériaux D (1988) Localized 1H NMR spectroscopy and spectroscopic imaging of human brain tumors in situ. 7th annual meeting of the Society of Magnetic Resonance in Medicine (abstracts). 20–26 August 1988, San Francisco, 1:252Google Scholar
  9. 9.
    Starewicz PM, Albright MJ (1986) Adaptation of a 1-meter bore magnetic resonance imaging system to in vivo decoupled carbon-13 spectroscopy. Health Care Instrumentation 1:212–215Google Scholar
  10. 10.
    Shulman RG (1983) NMR spectroscopy of living cells. Sci Amer 248:86CrossRefGoogle Scholar
  11. 11.
    Jue T, Rothman DL, Tavitian BA, Shulman RG (1988) 13C NMR hepatic glycogen repletion study in man. 7th annual meeting of the Society of Magnetic Resonance in Medicine (abstracts). 20–26 August 1988, San Francisco, 1:248Google Scholar
  12. 12.
    Radda GK (1985) Control of bioenergetics: from cell to man by phosphorus nuclear-magnetic-resonance spectroscopy (18th CIBA medal lecture). Biochem Soc Trans 14:517–525Google Scholar
  13. 13.
    Chance B, Leigh JS, Kent J, McCully K, Nioka S, Clark BJ, Maris JM, Graham T (1986) Multiple control of oxidative metabolism in living tissue as studied by phosphorus magnetic resonance. Proc Natl Acad Sci 83:9458–9462CrossRefGoogle Scholar
  14. 14.
    Bachert-Baumann P, Neurohr KJ, Gademann G, Semmler W, Zabel H-J, Lorenz W (1987) Klinische 31P-MR-Spektroskopie am Ganzkörpertomographen: Optimierung der Meßparameter und Lokalisierung. Zentralbl Radiol 134:237Google Scholar
  15. 15.
    Semmler W, Gademann G, Bachert-Baumann P, Zabel H-J, Lorenz W-J, van Kaick G (1988) Monitoring human tumor response to therapy by means of 31 P-MR spectroscopy. Radiology 166:533–539Google Scholar
  16. 16.
    Semmler W, Gademann G, Bachert-Baumann P, et al. (1988) In vivo 31 Phosphor-Spektroskopie von Tumoren: prä-, intra- und posttherapeutisch. ROFO 149: 369–377CrossRefGoogle Scholar
  17. 17.
    Semmler W, Gademann G, Schlag P, Bachert-Baumann P, et al. (1988) Impact of hyperthermic regional perfusion therapy on cell metabolism of malignant melanoma monitored by 31 P MR spectroscopy. Magn Res Imag 6:335–340CrossRefGoogle Scholar
  18. 18.
    Semmler W, Gademann G, Bachert-Baumann P, Zabel H-J, Lorenz W-J, van Kaick G (1988) Therapieverlaufskontrolle nach Chemotherapie an Tumoren des Menschen mit Hilfe der in-vivo 31 P-Spektroskopie. In: Schneider GH, Vogler E (eds) Digitale bildgebende Verfahren. Interventionale Verfahren. Integrierte digitale Radiologie. Springer, Berlin Heidelberg New York, pp 15–23CrossRefGoogle Scholar
  19. 19.
    Bottomley PA, Foster TH, Darrow RD (1984) Depth resolved surface-coil spectroscopy. J Magn Reson 59:338–342Google Scholar
  20. 20.
    Bottomley PA, Herfkens RJ, Smith LS, Bashore TM (1987) Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. Radiology 165:703–707Google Scholar
  21. 21.
    Sauter R, Müller S, Weber H (1987) Localization in in vivo 31P NMR spectroscopy by combining surface coils and slice-selective saturation. J Magn Reson 75:167–173Google Scholar
  22. 22.
    Ordidge RJ, Conelly A, Lohmann JAB (1986) Image-selected in vivo spectroscopy (ISIS). A new technique for specially selective NMR spectroscopy. J Magn Reson 66:283–294Google Scholar
  23. 23.
    Heindel W, Bunke J, Steinbrich W (1987) Bildgesteuerte lokalisierte 31P-NMR-Spektroskopie des menschlichen Gehirns bei 1,5 Tesla. ROFO 147:374–378CrossRefGoogle Scholar
  24. 24.
    Marson GB, Twieg DB, Karczmar GS, Lawry TJ, Gober JR, Valenza M, Boska MD, Weiner MW (1988) Application of image-guided surface coil P-31 MR spectroscopy to human liver, heart, and kidney. Radiology 169:541–547Google Scholar
  25. 25.
    Itoh M, lio M, Kawai M, Takizawa O, Yoshikawa K, Minausi M, Otitmo K, Aoki S, Niida T, Watanabe T (1986) 31P-NMR spectroscopy of myopathies: clinical application of whole-body MR. Rad Med 4:41–45Google Scholar
  26. 26.
    Bore PJ (1985) The role of magnetic resonance spectroscopy in clinical medicine. Magn Reson Imag 3:407–413CrossRefGoogle Scholar
  27. 27.
    Just M, Gutjahr P, Higer HP, Störkel S, Rudigier J, Ritter G, Pfannenstiel P (1987) Möglichkeiten der MR Tomographie in der Therapiekontrolle maligner Knochentumoren. ROFO 147:413–419CrossRefGoogle Scholar
  28. 28.
    Ross B, Helsper JT, Cox IJ, Young IR, Kempf R, Makepeace A, Pennock J (1987) Osteosarcoma and other neoplasms of bone. Magnetic resonance spectroscopy to monitor therapy. Arch Surg 122: 1464–1469CrossRefGoogle Scholar
  29. 29.
    Zabel H-J, Bader R, Gehrig J, Lorenz WJ (1987) High-quality MR imaging using flexible transmission line resonators. Radiology 165:857–859Google Scholar
  30. 30.
    Semmler W, Menningen M, Bachert-Baumann P, Gademann G, van Kaick G (1987) Quantitative evaluation of in-vivo 31P spectra using a least square fit procedure. 6th annual meeting of the Society of Magnetic Resonance in Medicine (abstracts). 17–21 August 1987, New York, p 505Google Scholar
  31. 31.
    Northrop J, Evans A, Doulon E, Haris J, Chance B (1986) Stage IV neuroblastoma response to chemo-therapy measured by 31P MRS in situ. 5th annual meeting of the Society of Magnetic Resonance in Medicine (abstracts). 19–22 August 1986, Montreal, 1:31Google Scholar
  32. 32.
    Nidecker AC, Müller S, Aue WP, Seelig J, Fridrich R, Remagen W, Hartweg H, Benz, UF (1985) Extremity bone tumors: Evaluation by P-31 MR spectroscopy. Radiology 157:167–174Google Scholar
  33. 33.
    Ng TC, Vijayakumar S, Majors AW, Thomas FJ, Meaney TF, Baldwin NJ (1987) Response of a NonHodgkin Lymphoma to 60Co therapy monitored by 31P MRS in situ. (lnt J Radiat Oncol Biol Phys) 13:1545–1551CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • W. Semmler
    • 1
  1. 1.Deutsches Krebsforschungszentrum HeidelbergInstitut für NuklearmedizinHeidelbergFederal Republic of Germany

Personalised recommendations